Ourania Tatsis, EVP, Chief Reg. & Quality Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 3,945 shares at $287.20 ($1.1M) on 2023-02-27, disclosed to the SEC on 2023-02-28.
Seasonal sale ($1.1M) by EVP, Chief Reg. & Quality Officer — this insider has traded VRTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $289.12 | 3,308 | $956K | 83.9% |
| 2 | $287.20 | 283 | $81K | 7.1% |
| 3 | $287.20 | 283 | $81K | 7.1% |
| 4 | $288.33 | 51 | $15K | 1.3% |
| 5 | $289.29 | 20 | $6K | 0.5% |
| Total | $288.84 avg | 3,945 |
| $1.1M |
| 100% |
| Filing → |
| VRTX | SELL | 2026-02-19 | $472K | — | Filing → |
| VRTX | SELL | 2026-02-18 | $750K | — | Filing → |
| VRTX | SELL | 2026-02-12 | $215K | — | Filing → |